| 张雪岩李学奇△ 李京秀闫述钧.重组人脑利钠肽的临床应用进展[J].,2014,14(20):3973-3976 |
| 重组人脑利钠肽的临床应用进展 |
| Advances in Clinical Application of Recombinant HumanBrain Natriuretic Peptide |
| |
| DOI： |
| 中文关键词: 重组人脑利钠肽 心力衰竭 肺动脉高压 临床应用 |
| 英文关键词: Recombinant human brain natriuretic peptide Heart failure Pulmonary hypertension Clinical application |
| 基金项目: |
|
| 摘要点击次数: 559 |
| 全文下载次数: 1474 |
| 中文摘要: |
| 摘要：近年来，随着心力衰竭、肺动脉高压的病理生理及分子机制的深入研究，使上述疾病在临床药物治疗方面有了很大的进步，
其中人脑利钠肽（BNP）作为体内唯一天然的肾素- 血管紧张素- 醛固酮拮抗剂在诊断及治疗心力衰竭等方面均引起了广泛关
注，但由于其在心衰状态下降解快且生物活性明显减弱而限制了临床应用。因此，在心力衰竭治疗上补充外源性BNP成为了又一
研究热点。重组人脑利钠肽（rhBNP）是一种人工合成的内源性激素,具有扩张血管、排钠利尿、降低心脏前后负荷、抑制肾素-血管
紧张素-醛固酮系统和交感神经系统等作用,能够有效的改善充血性心力衰竭患者的血流动力学障碍。新近研究表明，rhBNP 在
治疗心血管疾病方面疗效显著，本文将就其在临床中的应用予以综述。 |
| 英文摘要: |
| ABSTRACT:In recent years, with the further research of pathological physiological and molecular mechanism about heart failure
and pulmonary hypertension, the pharmacotherapy on these diseases have a great advance. The human brain natriuretic peptide (BNP), as
the only natural renin-angiotensin-aldosterone antagonist in the diagnosis and treatment of heart failure, caused wide public concern.
Therefore, exogenous BNP become one hot research spot in heart failure treatment. Recombinant human brain natriuretic peptide
(rhBNP) is a kind of synthetic endogenous hormone. It has the functions of vasodilation, diuresis, reducing the preload and afterload of
cardiac, inhibiting the renin-angiotensin-aldosterone system and sympathetic nervous system, and can effectively improve the
hemodynamic of congestive heart failure patients.Recent research shows that rhBNP have remarkable effection in the treatment of
cardiovascular diseases, so this article is aimed to review the clinical application of rhBNP. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
